Natural Killer Cell Malignancies: Clinical Trials

3 trials for Natural Killer Cell Malignancies, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 terminated. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 1, Recruiting 1, Terminated 1

Follow Natural Killer Cell Malignancies: new trials by email Literature Review of Natural Killer Cell Malignancies trials Research Report on Natural Killer Cell Malignancies

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
HSCT with TBI Regimen, HSCT with Non-TBI Regimen - Acute Leukemia, Acute Myeloid Leukemia
Phase 2RecruitingMasonic Cancer Center, University of Minnesota3002018-03-302026-06-25
UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep
Fludarabine, Cyclophosphamide, MMF - Acute Leukemia, Acute Myeloid Leukemia
Phase 2CompletedMasonic Cancer Center, University of Minnesota152017-05-152025-07-04
Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies
Infusion of Treg - Acute Lymphoblastic Leukemia, Burkitt Lymphoma
Phase 2TerminatedMasonic Cancer Center, University of Minnesota32017-02-162020-09-29

Narrower conditions

Burkitt Lymphoma (3)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (3)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (3)  ·  Leukemia, Myeloid, Acute (3)  ·  Leukemia, Prolymphocytic (3)  ·  Lymphoma, B-Cell, Marginal Zone (3)  ·  Lymphoma, Follicular (3)  ·  Lymphoma, Mantle-Cell (3)  ·  Multiple Myeloma (3)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (3)  ·  Dendritic Cell Sarcoma, Interdigitating (2)  ·  Hodgkin Disease (2)  ·  Leukemia, Plasma Cell (2)  ·  Myelodysplastic Syndromes (2)  ·  Myeloproliferative Disorders (2)

Broader conditions

Blood Protein Disorders (3)  ·  Bone Marrow Diseases (3)  ·  Cardiovascular Diseases (3)  ·  Chronic Disease (3)  ·  DNA Virus Infections (3)  ·  Disease Attributes (3)  ·  Epstein-Barr Virus Infections (3)  ·  Hematologic Diseases (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Hemorrhagic Disorders (3)  ·  Hemostatic Disorders (3)  ·  Herpesviridae Infections (3)  ·  Immune System Diseases (3)  ·  Immunoproliferative Disorders (3)  ·  Infections (3)

Interventions

Antilymphocyte Serum (1)  ·  Cyclophosphamide (1)  ·  Hematopoietic Stem Cell Transplantation (1)  ·  Mycophenolic Acid (1)  ·  Sirolimus (1)  ·  Whole-Body Irradiation (1)  ·  fludarabine (1)  ·  fludarabine phosphate (1)

Sponsors

Masonic Cancer Center, University of Minnesota (3)

Countries

United States (3)

Top investigators

Claudio Brunstein, MD, PhD (1)  ·  Margaret MacMillan, MD, MSC (1)  ·  Punita Grover, MD (1)